60 related articles for article (PubMed ID: 38560689)
1. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.
Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W
Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156
[TBL] [Abstract][Full Text] [Related]
2. Unveiling an oxidative stress-linked diagnostic signature and molecular subtypes in preeclampsia: novel insights into pathogenesis.
Mao R; Li L; Li P
Free Radic Res; 2024 Jun; ():1-12. PubMed ID: 38788124
[TBL] [Abstract][Full Text] [Related]
3. Modeling Melanoma Heterogeneity In Vitro: Redox, Resistance and Pigmentation Profiles.
Carvalho LADC; Noma IHY; Uehara AH; Siena ÁDD; Osaki LH; Mori MP; Pinto NCS; Freitas VM; Junior WAS; Smalley KSM; Maria-Engler SS
Antioxidants (Basel); 2024 Apr; 13(5):. PubMed ID: 38790661
[TBL] [Abstract][Full Text] [Related]
4. Integrative molecular and spatial analysis reveals evolutionary dynamics and tumor-immune interplay of in situ and invasive acral melanoma.
Liu H; Gao J; Feng M; Cheng J; Tang Y; Cao Q; Zhao Z; Meng Z; Zhang J; Zhang G; Zhang C; Zhao M; Yan Y; Wang Y; Xue R; Zhang N; Li H
Cancer Cell; 2024 May; ():. PubMed ID: 38759655
[TBL] [Abstract][Full Text] [Related]
5. Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data.
Shetty A; Wang S; Khan AB; English CW; Nouri SH; Magill ST; Raleigh DR; Klisch TJ; Harmanci AO; Patel AJ; Harmanci AS
J Neurooncol; 2024 Jun; ():. PubMed ID: 38834749
[No Abstract] [Full Text] [Related]
6. Integrative analysis of bulk and single-cell RNA-seq reveals the molecular characterization of the immune microenvironment and oxidative stress signature in melanoma.
Li Y; Jiang B; Chen B; Zou Y; Wang Y; Liu Q; Song B; Yu B
Heliyon; 2024 Mar; 10(6):e28244. PubMed ID: 38560689
[TBL] [Abstract][Full Text] [Related]
7. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
Shu J; Jiang J; Zhao G
Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
[TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
Mi K; Zeng L; Chen Y; Yang S
Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
[TBL] [Abstract][Full Text] [Related]
11. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
[TBL] [Abstract][Full Text] [Related]
12. PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity.
Gu Y; Lin X; Dong Y; Wood G; Seidah NG; Werstuck G; Major P; Bonert M; Kapoor A; Tang D
J Exp Clin Cancer Res; 2023 Jan; 42(1):2. PubMed ID: 36588164
[TBL] [Abstract][Full Text] [Related]
13. A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment.
Zhou X; Sun Q; Xu C; Zhou Z; Chen X; Zhu X; Huang Z; Wang W; Shi Y
Front Oncol; 2022; 12():952849. PubMed ID: 35982948
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
